InMed Pharmaceuticals Inc.
NASDAQ: INM0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Select
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Eric A. Adams Chem.
- Employees
- 13
- Headquarters
- Vancouver, Canada
- IPO year
- 2014
- Market cap
- $2.8M
- Website
- https://www.inmedpharma.com
Loading INM…
Loading profile data…Frequently asked questions about INM
What does InMed Pharmaceuticals Inc. (INM) do?
InMed Pharmaceuticals Inc. operates as a clinical-stage pharmaceutical firm, concentrating its efforts on the investigation and creation of therapeutic solutions derived from cannabinoids. Its primary product, INM-755, is a cannabinol-infused topical cream that is currently progressing through its second Phase I clinical trial for the management...
Where does INM trade?
InMed Pharmaceuticals Inc. (INM) trades on the NASDAQ Global Select.
What sector is INM in?
InMed Pharmaceuticals Inc. (INM) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of InMed Pharmaceuticals Inc.?
Eric A. Adams Chem. is the chief executive officer of InMed Pharmaceuticals Inc. (INM).
Where is InMed Pharmaceuticals Inc. headquartered?
InMed Pharmaceuticals Inc. is headquartered in Canada.
Does INM pay a dividend?
InMed Pharmaceuticals Inc. (INM) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did INM go public?
InMed Pharmaceuticals Inc. (INM) completed its initial public offering in 2014.